Methods of Administering Mesenchymal Stem Cells Activated by Cytokines for Enhancing Immunosuppression
Copyright © Targeted News Service 2024
2024-12-03
ALEXANDRIA, Virginia, Dec. 3 -- RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY, New Brunswick, New Jersey has been assigned a patent (No. US 12156889 B2, initially filed Jan. 15, 2021) developed by three inventors Yufang Shi, Belle Mead, New Jersey; Guangwen Ren, Bar Harbor, Maine; and Liying Zhang, Belle Mead, New Jersey, for "Methods of administering mesenchymal stem cells activated by cytokines for enhancing immunosuppression." . . .